How to buy Mednax stock (MD)

Mednax is a medical care facilities business based in the US. Mednax shares (MD) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $14.01 – a decrease of 1.13% over the previous week. Mednax employs 5,450 staff and has a trailing 12-month revenue of around $2 billion.

Our top picks for where to buy Mednax stock

Buy Mednax stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Mednax stock price (NYSE: MD)

Use our graph to track the performance of MD stocks over time.

Mednax shares at a glance

• Key figures

Information last updated 2024-12-11.

Latest market close	$14.01
52-week range	$6.62 - $16.41
50-day moving average more info button	$13.78
200-day moving average more info button	$10.13
Wall St. target price	$15.92
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.34

Is it a good time to buy Mednax stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mednax price performance over time

Historical closes compared with the close of $14.22 from 2024-12-17

1 week (2024-12-12)	0.35%
1 month (2024-11-19)	-2.67%
3 months (2024-09-19)	30.82%
6 months (2024-06-18)	84.44%

1 year (2023-12-19)	56.61%
2 years (2022-12-19)	-3.27%
3 years (2021-12-17)	25.83
5 years (2019-12-19)	27.9

Is Mednax stock undervalued or overvalued?

Valuing Mednax stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mednax's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Mednax's PEG ratio

Mednax's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.88. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Mednax's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Mednax's EBITDA

Mednax's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $199 million.

The EBITDA is a measure of a Mednax's overall financial performance and is widely used to measure a its profitability.

Mednax financials

Revenue TTM	$2 billion
Operating margin TTM	10.26%
Gross profit TTM	$467 million
Return on assets TTM	4.67%
Return on equity TTM	-29.86%
Profit margin	-12.65%
Book value	$8.67
Market Capitalization more info button	$1.2 billion

TTM: trailing 12 months

Mednax share dividends

We're not expecting Mednax to pay a dividend over the next 12 months.

Have Mednax's shares ever split?

Mednax's shares were split on a 2:1 basis on 19 December 2013 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Mednax shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Mednax shares which in turn could have impacted Mednax's share price.

Mednax share price volatility

Over the last 12 months, Mednax's shares have ranged in value from as little as $6.62 up to $16.41. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Mednax's is 1.555. This would suggest that Mednax's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Mednax overview

Pediatrix Medical Group, Inc. , together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc.

Frequently asked questions

What percentage of Mednax is owned by insiders or institutions?
Currently 1.687% of Mednax shares are held by insiders and 107.001% by institutions. How many people work for Mednax?
Latest data suggests 5,450 work at Mednax. When does the fiscal year end for Mednax?
Mednax's fiscal year ends in December. Where is Mednax based?
Mednax's address is: 1301 Concord Terrace, Sunrise, FL, United States, 33323 What is Mednax's ISIN number?
Mednax's international securities identification number is: US58502B1061 What is Mednax's CUSIP number?
Mednax's Committee on Uniform Securities Identification Procedures number is: 705324101